Behina Bazghandi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Behina Bazghandi has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Alireza Raghibi
Department of Medical Genetics, School of Medicine Tehran University of Medical Sciences Tehran Iran
1 shared publication - Amirhossein Mohajeri Khorasani
Medical Genetics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
1 shared publication - Behzad Haj Mohammad Hassani
Department of Medical Genetics, Faculty of Medicine, Hormozgan University of Medical Sciences, Bandar Abbas, Iran
1 shared publication - Ehsan Saburi
Department of Medical Genetics and Molecular Medicine, Faculty of Medicine Mashhad University of Medical Sciences Mashhad Iran
1 shared publication - Fatemeh Forouzanfar
Medical Toxicology Research Center, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
1 shared publication - Fatemeh Rahimzadeh-Bajgiran
Department of Biology, Mashhad branch, Islamic Azad university, Mashhad, Iran
1 shared publication
Latest Publications
- Open Access
- 25 April 2024
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 24 (1) , 1-19
miR-17-92a-1 cluster host gene: a key regulator in colorectal cancer development and progression
Colorectal cancer (CRC), recognized among the five most prevalent malignancies and most deadly cancers, manifests multifactorial influences stemming from environmental exposures, dietary patterns, age, and genetic predisposition. Although substantial progress has been made in comprehending the etiology of CRC, the precise genetic components driving its pathogenesis remain incompletely elucidated. Within the expansive repertoire of non-coding RNAs, particular focus has centered on the miR-17-92a-1 cluster host gene (MIR17HG) and its associated miRNAs, which actively participate in diverse cellular processes and frequently exhibit heightened expression in various solid tumors, notably CRC. Therefore, the primary objective of this research is to undertake an extensive inquiry into the regulatory mechanisms, structural features, functional attributes, and potential diagnostic and therapeutic implications associated with this cluster in CRC. Furthermore, the intricate interplay between this cluster and the development and progression of CRC will be explored. Our findings underscore the upregulation of the miR-17-92a-1 cluster host gene (MIR17HG) and its associated miRNAs in CRC compared to normal tissues, thus implying their profound involvement in the progression of CRC. Collectively, these molecules are implicated in critical oncogenic processes, encompassing metastatic activity, regulation of apoptotic pathways, cellular proliferation, and drug resistance. Consequently, these findings shed illuminating insights into the potential of MIR17HG and its associated miRNAs as promising targets for therapeutic interventions in the management of CRC. Graphical abstract
- 25 April 2024
- Published by Springer Nature in Clinical and Experimental Medicine
- Vol. 24 (1) , 1-19
Open AccessmiR-17-92a-1 cluster host gene: a key regulator in colorectal cancer development and progression
Colorectal cancer (CRC), recognized among the five most prevalent malignancies and most deadly cancers, manifests multifactorial influences stemming from environmental exposures, dietary patterns, age, and genetic predisposition. Although substantial progress has been made in comprehending the etiology of CRC, the precise genetic components driving its pathogenesis remain incompletely elucidated. Within the expansive repertoire of non-coding RNAs, particular focus has centered on the miR-17-92a-1 cluster host gene (MIR17HG) and its associated miRNAs, which actively participate in diverse cellular processes and frequently exhibit heightened expression in various solid tumors, notably CRC. Therefore, the primary objective of this research is to undertake an extensive inquiry into the regulatory mechanisms, structural features, functional attributes, and potential diagnostic and therapeutic implications associated with this cluster in CRC. Furthermore, the intricate interplay between this cluster and the development and progression of CRC will be explored. Our findings underscore the upregulation of the miR-17-92a-1 cluster host gene (MIR17HG) and its associated miRNAs in CRC compared to normal tissues, thus implying their profound involvement in the progression of CRC. Collectively, these molecules are implicated in critical oncogenic processes, encompassing metastatic activity, regulation of apoptotic pathways, cellular proliferation, and drug resistance. Consequently, these findings shed illuminating insights into the potential of MIR17HG and its associated miRNAs as promising targets for therapeutic interventions in the management of CRC. Graphical abstract
- 29 March 2024
- Published by Elsevier in European Journal of Pharmacology
- Vol. 971, 176527
Therapeutic potential of lipid-lowering probiotics on the atherosclerosis development
- 29 March 2024
- Published by Elsevier in European Journal of Pharmacology
- Vol. 971, 176527
Therapeutic potential of lipid-lowering probiotics on the atherosclerosis development